Effect of 5-HT depletion by MDMA on hyperthermia and Arc mRNA induction in rat brain

Psychopharmacology

Volumn 173, Issue 3-4, 2004, Pages 346-352

  Beveridge, Thomas J R ^a,c   Mechan, Annis O ^a,d   Sprakes, Marie ^b   Pei, Qi ^b   Zetterstrom, Tyra S C ^a   Green, A Richard ^a   Elliott, J Martin ^a  

^a DE MONTFORT UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT depletion; Arc; Hyperthermia; Immediate early genes; MDMA; Neurotoxicity; Rat brain; Synaptic plasticity

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; MESSENGER RNA; OLIGONUCLEOTIDE; SEROTONIN; SULFUR 35;

ACTIVITY REGULATED CYTOSKELETON ASSOCIATED GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; CONTROLLED STUDY; GENE; HIPPOCAMPUS; HISTOCHEMISTRY; HYPERTHERMIA; HYPOTHALAMUS; IN SITU HYBRIDIZATION; ISOTOPE LABELING; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN;

ANIMALS; BRAIN; CYTOSKELETAL PROTEINS; FEVER; IMMEDIATE-EARLY PROTEINS; IN SITU HYBRIDIZATION; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NERVE TISSUE PROTEINS; RATS; RNA, MESSENGER; SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 2542570145     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1753-y     Document Type: Article

References (41)

1. Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB (1987) 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. J Pharmacol Exp Ther 242:911-916
2. Bhattachary S, Powell JH (2001) Recreational use of 3,4- methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment. Psychol Med 31:647-658
3. Brodkin J, Malyala A, Nash JF (1993) Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity. Pharmacol Biochem Behav 45:647-653
4. Broening HW, Morford LL, Inman-Wood SL, Fukumura M, Vorhees CV (2001) 3,4-methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development. J Neurosci 21:3228-3235
5. Castro E, Tordera RM, Hughes ZA, Pei Q, Sharp T (2003) Use of Arc expression as a molecular marker of increased postsynaptic 5-HT function after SSRI/5-HT1A receptor antagonist co-administration. J Neurochem 85:1480-1487
6. Colado MI, Williams JL, Green AR (1995) The hyperthermic and neurotoxic effects of 'ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the dark agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype. Br J Pharmacol 115:1281-1289
7. Dafters RI (1995) Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing. Physiol Behav 58:877-882
8. Fosnaugh JS, Bhat RV, Yamagata K, Worley PF, Baraban JM (1995) Activation of arc, a putative "effector" immediate early gene, by cocaine in rat brain. J Neurochem 64:2377-2380
9. Gartside SE, McQuade R, Sharp T (1996) Effects of repeated administration of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo. J Pharmacol Exp Ther 279:277-283
10. Gough B, Ali SF, Slikker W Jr, Holson RR (1991) Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate. Pharmacol Biochem Behav 39:619-623
11. Green AR, Elliott JM, Colado MI (2003a) Effects of ambient temperature and 3,4-methylenedioxymethamphetamine (MDMA) pretreatment on the hyperthermic response of rats to a low dose of MDMA. Br J Pharmacol 138:196P
12. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI (2003b) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 55:463-508
13. Guzowski JF, Lyford GL, Stevenson GD, Houston FP, McGaugh JL, Worley PF, Barnes CA (2000) Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory. J Neurosci 20:3993-4001
14. Hewitt KE, Green AR (1994) Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('ecstasy') to rats. Neuropharmacology 33:1589-1595
15. Kodama M, Akiyama K, Ujike H, Shimizu Y, Tanaka Y, Kuroda S (1998) A robust increase in expression of arc gene, an effector immediate early gene, in the rat brain after acute and chronic methamphetamine administration. Brain Res 796:273-283
16. Krystal JH, Price LH, Opsahl C, Ricaurte GA, Heninger GR (1992) Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function? Am J Drug Alcohol Abuse 18:331-341
17. Lyford GL, Yamagata K, Kaufmann WE, Barnes CA, Sanders LK, Copeland NG, Gilbert DJ, Jenkins NA, Lanahan AA, Worley PF (1995) Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 14:433-445
18. Malpass A, White JM, Irvine RJ, Somogyi AA, Bochner F (1999) Acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA) in Sprague-Dawley and dark agouti rats. Pharmacol Biochem Behav 64:29-34
19. Marston HM, Reid ME, Lawrence JA, Olverman HJ, Butcher SP (1999) Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat. Psychopharmacology 144:67-76
20. McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA (1998) Positron emission tomographic evidence of toxic effect of MDMA ("ecstasy") on brain serotonin neurons in human beings. Lancet 352:1433-1437
21. Mechan AO, O'Shea E, Elliott JM, Colado MI, Green AR (2001) A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long-term defect in thermoregulation. Psychopharmacology 155:413-418
22. Mechan AO, Esteban B, O'Shea E, Elliott JM, Colado MI, Green AR (2002a) The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats. Br J Pharmacol 135:170-180
23. Mechan AO, Moran PM, Elliott M, Young AJ, Joseph MH, Green R (2002b) A study of the effect of a single neurotoxic dose of 3,4- methylenedioxymethamphetamine (MDMA; "ecstasy") on the subsequent long-term behaviour of rats in the plus maze and open field. Psychopharmacology 159:167-175
24. Milton AS (1977) The hypothalamus and the pharmacology of thermoregulation. In: Cox B, Morris ID, Weston AD (eds) Pharmacology of the hypothalamus. Macmillan Press Ltd, London
25. O'Hearn E, Battaglia G, De Souza EB, Kuhar MJ, Molliver ME (1988) Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J Neurosci 8:2788-2803
26. O'Shea E, Granados R, Esteban B, Colado MI, Green AR (1998) The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy'). Neuropharmacology 37:919-926
27. Parrott AC (2001) Human psychopharmacology of ecstasy (MDMA): a review of 15 years of empirical research. Hum Psychopharmacol 16:557-577
28. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, London
29. Pei Q, Lewis L, Sprakes ME, Jones EJ, Grahame-Smith DG, Zetterstrom TS (2000) Serotonergic regulation of mRNA expression of Arc, an immediate early gene selectively localized at neuronal dendrites. Neuropharmacology 39:463-470
30. Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W (2001) Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet 358:1864-1869
31. Sabol KE, Lew R, Richards JB, Vosmer GL, Seiden LS (1996) Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I. Synaptosomal uptake and tissue concentrations. J Pharmacol Exp Ther 276:846-854
32. Semple DM, Ebmeier KP, Glabus MF, O'Carroll RE, Johnstone EC (1999) Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users. Br J Psychiatry 175:63-69
33. Series HG, Cowen PJ, Sharp T (1994) p-Chloroamphetamine (PCA), 3,4-methylenedioxy-metnamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo. Psychopharmacology 116:508-514
34. Series HG, le Masurier M, Gartside SE, Franklin M, Sharp T (1995) Behavioural and neuroendocrine response to D-fenfluramine in rats treated with neurotoxic amphetamines. J Psychopharmacol 9:214-222
35. Shankaran M, Gudelsky GA (1999) A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration. Psychopharmacology 147:66-72
36. Shirayama Y, Hashimoto K, Iyo M, Watanabe K, Higuchi T, Minabe Y (2000) 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA in rat brain: pharmacological manipulation. Eur J Pharmacol 402:215-222
37. Slikker W Jr, Holson RR, Ali SF, Kolta MG, Paule MG, Scallet AC, McMillan DE, Bailey JR, Hong JS, Scalzo FM (1989) Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate. Neurotoxicology 10:529-542
38. Stephenson CP, Hunt GE, Topple AN, McGregor IS (1999) The distribution of 3,4-methylenedioxymethamphetamine "ecstasy"-induced c-fos expression in rat brain. Neuroscience 92:1011-1023
39. Steward O, Worley PF (2001a) A cellular mechanism for targeting newly synthesized mRNAs to synaptic sites on dendrites. Proc Natl Acad Sci U S A 98:7062-7068
40. Steward O, Worley PF (2001b) Selective targeting of newly synthesized Arc mRNA to active synapses requires NMDA receptor activation. Neuron 30:227-240
41. Temple MD, Worley PF, Steward O (2003) Visualizing changes in circuit activity resulting from denervation and reinnervation using immediate early gene expression. J Neurosci 23:2779-2788